Citation: Nj. Wareham et Sj. Griffin, Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria, BR MED J, 322(7292), 2001, pp. 986-988
Citation: Sj. Griffin et al., Development of a novel ultrasound monitoring system for container filling operations, J MATER PR, 109(1-2), 2001, pp. 72-77
Authors:
Renders, CM
Valk, GD
Griffin, SJ
Wagner, EH
Van, JTME
Assendelft, WJJ
Citation: Cm. Renders et al., Interventions to improve the management of diabetes in primary care, outpatient, and community settings - A systematic review, DIABET CARE, 24(10), 2001, pp. 1821-1833
Citation: Sj. Griffin et al., Diabetes risk score: Towards earlier detection of Type 2 diabetes in general practice, DIABET M R, 16(3), 2000, pp. 164-171
Authors:
Park, PJ
Griffin, SJ
Duffy, SW
Wareham, NJ
Citation: Pj. Park et al., The effect of varying the screening interval on false positives and duration of undiagnosed disease in a screening programme for type 2 diabetes, J MED SCREE, 7(2), 2000, pp. 91-96
Authors:
Huddleston, JG
Willauer, HD
Griffin, SJ
Rogers, RD
Citation: Jg. Huddleston et al., Aqueous polymeric solutions as environmentally benign liquid liquid extraction media, IND ENG RES, 38(7), 1999, pp. 2523-2539
Authors:
Woodcock, AJ
Kinmonth, AL
Campbell, MJ
Griffin, SJ
Spiegal, NM
Citation: Aj. Woodcock et al., Diabetes Care from Diagnosis: Effects of training in patient-centred care on beliefs, attitudes and behaviour of primary care professionals, PAT EDUC C, 37(1), 1999, pp. 65-79
Authors:
McGinnity, DF
Griffin, SJ
Moody, GC
Voice, M
Hanlon, S
Friedberg, T
Riley, RJ
Citation: Df. Mcginnity et al., Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli, DRUG META D, 27(9), 1999, pp. 1017-1023
Citation: Gc. Moody et al., Fully automated analysis of activities catalysed by the major human liver cytochrome P450(CYP) enzymes: assessment of human CYP inhibition potential, XENOBIOTICA, 29(1), 1999, pp. 53-75